Table 1.
NVU Component | Exosome Cargo | Target | Effects of Dysregulation | References |
---|---|---|---|---|
Neural-derived exosomes | miR-181c-3p | Downregulating CXCL1 in astrocytes | Protective effects on neuroinflammation | Song et al. [40] |
miR-98 | Targeting PAFR | Inhibit microglial phagocytosis; Ameliorate ischemia-induced neuronal death |
Yang et al. [41] | |
miR-132 | Regulating VE-cadherin by targeting eef2k | Maintain vascular integrity | Xu et al. [42] | |
Oligodendrocyte-derived exosomes | Antioxidant enzymes (catalase and SOD1) | Activating pro-survival pathways (Akt, ERK1, and ERK2) | Promote neuronal survival; Enhance stress tolerance |
Fröhlich et al. [50] |
Astrocyte-derived exosomes | miR-190b | Targeting Atg7 | Inhibit apoptosis; Suppress autophagy; Ameliorate ischemia-induced neuronal damage |
Pei et al. [59,60] |
circSHOC2 | Acting on the miR-7670-3p/SIRT1 axis; Regulating autophagy |
Inhibit apoptosis; Promote autophagy; Ameliorate neuronal damage |
Chen et al. [62] | |
miR-361 | Downregulating the AMPK/mTOR pathway and targeting CTSB | Suppress cell apoptosis; Ameliorate nerve damage |
Bu et al. [63] | |
miR-34c | Downregulating the NF-κB/MAPK axis by targeting TLR7 | Suppress cell apoptosis; Ameliorate nerve damage |
Wu et al. [64] | |
miR-30c-2-3p ↓ miR-326-5p ↓ (from Sema3A inhibitor-treated ischemic As-Exos) |
Increasing prostaglandin D2 synthase | Suppress astrocyte activation; Promote axonal outgrowth and functional recovery |
Hira et al. [65] | |
synapsin 1 | - | Increase neurite outgrowth and survival; Modulate neuron–glia interaction |
Wang et al. [66] | |
miR-92b-3p | - | Ameliorate ischemia-induced neuronal apoptosis and injury | Xu et al. [70] | |
Microglia-derived exosomes | miR-124 from Mi2-Exos) | Targeting USP14 | Attenuate ischemic brain injury, neural deficits, apoptosis; Promote neuronal survival |
Song et al. [73] |
Downregulating STAT3 | Reduce glial scar formation; Improve post-stroke recovery; Inhibit the migration and proliferation of astrocytes |
Li et al. [74] | ||
Increasing Sox2, decreasing Notch1 expression | Promote astrocyte-to-neural progenitor cell transition | |||
miRNA-26a (from IL-4 polarized Mi-Exos) | - | Promote angiogenesis | Tian et al. [75] | |
miR-424-5p | Regulating the FGF2/STAT3 pathway | Induce cell damage and permeability of BMECs | Xie et al. [76] | |
Endothelial cell-derived exosomes | miR-126-3p | - | Increase neurite outgrowth; Protect PC12 cells from nerve damage and apoptosis |
Gao et al. [81] |
miR-27a miR-19a miR-298 miR-195 |
Targeting Sema6A, PTEN, and RhoA | Promote the axonal growth of cortical neurons | Zhang et al. [82] | |
miR-126 | - | Promote axon, myelin, and vascular density and M2 macrophage polarization in diabetic stroke; Improve functional and cognitive functional outcomes |
Venkat et al. [85] | |
Endothelial progenitor cell-derived exosomes | miR-210 | Improving mitochondrial function | Improve angiogenic function; Decrease apoptosis and reactive oxygen species production |
Ma et al. [84] |
miR-126 | Downregulating cleaved caspase-3; Upregulating VEGFR2 | Promote neurogenesis and angiogenesis; Improve neurological function recovery |
Wang et al. [86] |
Abbreviations: CXCL1, chemokine CXC motif ligand 1; PAFR, platelet activating factor receptor; VE-cadherin, vascular endothelial cadherin; eef2k, eukaryotic elongation factor 2 kinase; SOD1, superoxide dismutase 1; ERK1 and ERK2, extracellular signal-regulated protein kinases 1 and 2; Atg7, autophagy-related gene 7; SIRT1, sirtuin 1; AMPK, AMP-activated protein kinase; mTOR, mammalian target of rapamycin; CTSB, cathepsin B; NF-κB, nuclear factor-kappa B; MAPK, mitogen-activated protein kinase; TLR7, toll-like receptor 7; Sema3A, semaphorin 3A; As-Exos, astrocytes-derived exosomes; Mi2-Exos, M2 microglia-derived exosomes; USP14, ubiquitin-specific protease 14; STAT3, signal transducer and activator of transcription 3; IL-4, interleukin-4; FGF2, basic fibroblast growth factor; BMEC, brain microvascular endothelial cell; Sema 6A, semaphorin 6A; PTEN, phosphatase and tensin homolog; RhoA, ras homolog family member A; VEGFR2, vascular endothelial growth factor receptor 2.